Bringing it home: SA is leading the charge to make anti-HIV jab for Africa 
/ 9 March 2026

Bringing it home: SA is leading the charge to make anti-HIV jab for Africa 

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July.

No need for pad panic, experts say
/ 6 March 2026

No need for pad panic, experts say

Together with sanitary pad and pantyliner manufacturers, specialists say there is no evidence of a health risk even though a UFS study has found they contain hormone-disrupting chemicals

Two superbugs causing over half of infections that kill newborns in Soweto and outsmarting treatment
/ 10 November 2025

Two superbugs causing over half of infections that kill newborns in Soweto and outsmarting treatment

Over the past 10 years, researchers from the University of the Witwatersrand’s vaccines and infectious diseases analytics unit analysed small tissue samples of 1 586 children under five who died at public health facilities in Soweto, southwest of Johannesburg.  With the people in the area living in from informal settlements to structured houses, the cases […]